CompuGroup Medical SE & Co. KGaA
CMPVF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.87 | -1.22 | 0.00 | -5.82 |
| FCF Yield | 7.04% | 6.21% | 4.14% | 2.61% |
| EV / EBITDA | 8.24 | 12.60 | 10.67 | 20.99 |
| Quality | ||||
| ROIC | 3.52% | 5.87% | 5.26% | 5.34% |
| Gross Margin | 83.64% | 17.40% | 30.51% | 27.88% |
| Cash Conversion Ratio | 3.71 | 3.91 | 1.98 | 2.40 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.54% | 0.63% | 5.68% | 11.66% |
| Free Cash Flow Growth | -46.73% | 67.84% | -31.14% | -7.47% |
| Safety | ||||
| Net Debt / EBITDA | 3.74 | 3.27 | 3.15 | 3.15 |
| Interest Coverage | 2.81 | 6.67 | 10.45 | 13.85 |
| Efficiency | ||||
| Inventory Turnover | 12.84 | 51.96 | 26.67 | 35.82 |
| Cash Conversion Cycle | -88.20 | 37.00 | -35.24 | -30.28 |